Ciprofloxacin Hcl –cipro - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost And Revenue
|PRODUCT PROFILE Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It is a second generation fluoroquinolone antibacterial. It works by stopping the growth of bacteria and kills bacteria by interfering with the enzymes that cause DNA to rewind after being copied, which stops synthesis of DNA and of protein. Ciprofloxacin interacts with other drugs, herbal and natural supplements, and thyroid medications. Ciprofloxacin was first patented in 1983 by Bayer A.G. and subsequently approved by the U.S. Food and Drug Administration (FDA) in 1987. Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1 cyclopropyl 6 fluoro 1, 4 dihydro 4 oxo 7 (1 piperazinyl) 3 quinolinecarboxylic acid. Ciprofloxacin inhibits an enzyme called DNA gyrase that is an essential component of the mechanism that passes genetic information onto daighter cells when a cell divides. Product characteristics Trade names - Ciloxan, Cipro Mol. Formula. - C17H18FN3O3HCl.H2O Molecular weight - 385.8 Appearance - Powder; does not mix well with water. Description - Antibiotic Shelf life - Good Bioavailability - 69% State - Solid, Divided solid Applications Ciprofloxacin is used to treat a number of infections including: infections of bones and joints, endocarditis, gastroenteritis, malignant otitis externa, respiratory tract infections, cellulitis, urinary tract infections, prostatitis, anthrax, chancroid, among others. Ciprofloxacin is available as tablets, intravenous solutions, eye and ear drops. It can also be used to treat some sexually transmitted infections (STIs), some forms of infectious diarrhea, and typhoid fever. The extended release form of ciprofloxacin is used to treat bladder and kidney infections. Global demand • India accounts for less than two per cent of the world market for pharmaceuticals, with an estimated market value of US$10.4 billion in 2007 at consumer prices, or around US$9 per capita. • Espicom's market projections put the market at US$15.6 billion by 2012 by assuming a modest but sustainable market growth of around 8.4% per year. • However, McKinsey has predicted that just the Indian domestic market alone is expected to grow from US$6.3 billion in 2005 to about US$20 billion by 2015. • The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. However, the Indian industry, valued at USD 17 bn in represented just over 1% of the global pharmaceutical industry (USD 1700 bn) in value terms. The domestic market is estimated at Rs 680 bn. The demand of Ciprofloxacin in the market is immense and therefore its market position is splendid. Hence it is an excellent field to venture.|
|Plant capacity: 180 MT/ Annum||Plant & machinery: 225 Lakhs|
|Working capital: -||T.C.I: Cost of project: 549 Lakhs|
|Return: 43.00%||Break even: 59.00%|
|Email Us | Add to Inquiry Basket|
We can provide you detailed project reports on the following topics. Please select the projects of your interests.
Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.
We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.
Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.Information
- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
About NIIR PROJECT CONSULTANCY SERVICES
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. Its various services are: Pre-feasibility study, New Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Preparation of Project Profiles and Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects and industry.
NPCS also publishes varies technology books, directory, databases, detailed project reports, market survey reports on various industries and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by Indian and overseas professionals including project engineers, information services bureau, consultants and consultancy firms as one of the input in their research.
Products & Services